Athersys Investor Relations Material
Latest events
Investor Update
Athersys
Q3 2023
16 Nov, 2023
Investor Presentation
24 Aug, 2023
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Athersys Inc
Access all reports
Athersys Inc is a biotechnology company focused on the research and development of regenerative medicine therapies. Its lead programs involve cell-based therapies for treating neurological conditions, inflammatory diseases, and cardiovascular indications. The company is headquartered in Cleveland, Ohio, and its shares are listed on the NASDAQ.
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
ATHX
Country
🇺🇸 United States